%0 Journal Article
%9 ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES
%A Sakana, B. Leticia D.
%A Mennecier, A.
%A Fao, P.
%A Tassembedo, S.
%A Moles, J.-P.
%A Kania, D.
%A Taofiki, A. O.
%A Kadeba, F. E.
%A Diallo, I.
%A Eymard-Duvernay, Sabrina
%A D'Ottavi, M.
%A Meda, N.
%A Mosqueira, B.
%A Van de Perre, P.
%A Nagot, N.
%A ANRS 12388 PREVENIR-PEV Study Group,
%T Prevention of mother-to-child transmission of HIV at the second immunization visit : a cross-sectional study, Burkina Faso
%D 2022
%L fdi:010090459
%G ENG
%J Bulletin of the World Health Organization
%@ 0042-9686
%K BURKINA FASO
%M ISI:000923446600016
%N 12
%P 769-776
%R 10.2471/blt.22.288522
%U https://www.documentation.ird.fr/hor/fdi:010090459
%> https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2023-11/010090459.pdf
%V 100
%W Horizon (IRD)
%X Objective : To evaluate the performance of the cascade of activities for prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV) at the second immunization visit in Burkina Faso. Methods : In a cross-sectional study, we recruited mothers attending the second immunization visit for their infant in 20 health centres of Bobo-Dioulasso city, Burkina Faso over 12 months (2019-2020). We administered a short questionnaire to 14 176 mothers and performed HIV serological tests on mothers who had not been tested in the last 3 months. All mothers were asked about their attendance for antenatal care and HIV rapid testing. HIV-infected mothers were also asked about the timing of their HIV diagnosis, antiretroviral therapy, pre-exposure prophylaxis initiation at birth and infant diagnosis of HIV. Findings Of 14 136 respondents, 13 738 (97.2%) had at least one HIV serological test in their lifetime. Of 13 078 mothers who were never tested or were HIV-negative, 12 454 (95.2%) were tested during or after their last pregnancy. Among HIV-infected mothers already aware of their status, 110/111 (99.1%) women were on antiretroviral therapy. Among HIV-exposed infants, 84/101 (83.2%) babies received 6 weeks of antiretroviral prophylaxis at birth and 58/110 (52.7%) had a blood sample collected for early infant diagnosis. Only two mothers received their child's test results at the time of the second immunization visit. Four mothers were newly diagnosed as HIV-positive during the study. Conclusion : Collecting data at the second immunization visit, a visit rarely missed by mothers, could be useful for identifying gaps in the PMTCT cascade in settings where mothers are difficult to reach, such as in low-income countries with intermediate or low HIV prevalence.
%$ 052MALTRA03 ; 050MEDECI